MKK6-p38 MAPK signaling pathway enhances survival but not bone-resorbing activity of osteoclasts

Biochemical and Biophysical Research Communications

Volumn 365, Issue 2, 2008, Pages 252-257

  Yamashita, Teruhito ^a   Kobayashi, Yasuhiro ^a   Mizoguchi, Toshihide ^a   Yamaki, Mariko ^a   Miura, Toshiki ^b   Tanaka, Sakae ^b   Udagawa, Nobuyuki ^a   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone resorption; Cell survival; Inflammation; Interleukin 1; MKK6; Osteoclasts; p38 MAP kinase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DENTIN; EMBRYO; ENZYME PHOSPHORYLATION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY DISEASE; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; BONE RESORPTION; CELL SURVIVAL; CELLS, CULTURED; MAP KINASE KINASE 6; MAP KINASE SIGNALING SYSTEM; MICE; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 36249022727     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.169     Document Type: Article

References (30)

1. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
2. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20 (1999) 345-357
3. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., and Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
4. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602
5. Suda T., Nakamura I., Jimi E., and Takahashi N. Regulation of osteoclast function. J. Bone Miner. Res. 12 (1997) 869-879
6. Jimi E., Akiyama S., Tsurukai T., Okahashi N., Kobayashi K., Udagawa N., Nishihara T., Takahashi N., and Suda T. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163 (1999) 434-442
7. Jimi E., Nakamura I., Ikebe T., Akiyama S., Takahashi N., and Suda T. Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J. Biol. Chem. 273 (1998) 8799-8805
8. Jimi E., Nakamura I., Duong L.T., Ikebe T., Takahashi N., Rodan G.A., and Suda T. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247 (1999) 84-93
9. Itoh K., Udagawa N., Kobayashi K., Suda K., Li X., Takami M., Okahashi N., Nishihara T., and Takahashi N. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 170 (2003) 3688-3695
10. Saltel F., Destaing O., Bard F., Eichert D., and Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol. Biol. Cell 15 (2004) 5231-5241
11. Vaananen H.K., Zhao H., Mulari M., and Halleen J.M. The cell biology of osteoclast function. J. Cell Sci. 113 (2000) 377-381
12. Aicher A., Shu G.L., Magaletti D., Mulvania T., Pezzutto A., Craxton A., and Clark E.A. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 163 (1999) 5786-5795
13. Engel F.B., Hsieh P.C., Lee R.T., and Keating M.T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. USA 103 (2006) 15546-15551
14. Engelman J.A., Lisanti M.P., and Scherer P.E. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J. Biol. Chem. 273 (1998) 32111-32120
15. Morooka T., and Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273 (1998) 24285-24288
16. Li X., Udagawa N., Takami M., Sato N., Kobayashi Y., and Takahashi N. p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 144 (2003) 4999-5005
17. Ridley S.H., Sarsfield S.J., Lee J.C., Bigg H.F., Cawston T.E., Taylor D.J., DeWitt D.L., and Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158 (1997) 3165-3173
18. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., and Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16 (1996) 1247-1255
19. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Keys J.R., Land vatter S.W., Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., and Young P.R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
20. Li X., Udagawa N., Itoh K., Suda K., Murase Y., Nishihara T., Suda T., and Takahashi N. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143 (2002) 3105-3113
21. Matsumoto M., Sudo T., Saito T., Osada H., and Tsujimoto M. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem. 275 (2000) 31155-31161
22. Hayer S., Steiner G., Gortz B., Reiter E., Tohidast-Akrad M., Amling M., Hoffmann O., Redlich K., Zwerina J., Skriner K., Hilberg F., Wagner E.F., Smolen J.S., and Schett G. CD44 is a determinant of inflammatory bone loss. J. Exp. Med. 201 (2005) 903-914
23. Yamamoto A., Fukuda A., Seto H., Miyazaki T., Kadono Y., Sawada Y., Nakamura I., Katagiri H., Asano T., Tanaka Y., Oda H., Nakamura K., and Tanaka S. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts. Arthritis Rheum. 48 (2003) 2682-2692
24. Takahashi N., Udagawa N., Tanaka S., and Suda T. Generating murine osteoclasts from bone marrow. Methods Mol. Med. 80 (2003) 129-144
25. Seto H., Kamekura S., Miura T., Yamamoto A., Chikuda H., Ogata T., Hiraoka H., Oda H., Nakamura K., Kurosawa H., Chug U.I., Kawaguchi H., and Tanaka S. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. J. Clin. Invest. 113 (2004) 718-726
26. Okumura S., Mizoguchi T., Sato N., Yamaki M., Kobayashi Y., Yamauchi H., Ozawa H., Udagawa N., and Takahashi N. Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks. Bone 39 (2006) 684-693
27. Baldassare J.J., Bi Y., and Bellone C.J. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162 (1999) 5367-5373
28. Park J.M., Greten F.R., Wong A., Westrick R.J., Arthur J.S., Otsu K., Hoffmann A., Montminy M., and Karin M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity 23 (2005) 319-329
29. Miyazaki T., Katagiri H., Kanegae Y., Takayanagi H., Sawada Y., Yamamoto A., Pando M.P., Asano T., Verma I.M., Oda H., Nakamura K., and Tanaka S. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J. Cell Biol. 148 (2000) 333-342
30. Akiyama T., Bouillet P., Miyazaki T., Kadono Y., Chikuda H., Chung U.I., Fukuda A., Hikita A., Seto H., Okada T., Inaba T., Sanjay A., Baron R., Kawaguchi H., Oda H., Nakamura K., Strasser A., and Tanaka S. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22 (2003) 6653-6664